Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
CytomX Therapeutics $100 million stock offering
The stock is listed on the Nasdaq Global Select Market
Bank of America $5 billion floating-rate and fixed-to-floating-rate notes
The investment-grade debt offering is based on the Secured Overnight Financing Rate
Bank of America $3 billion preferred stock offering
The company issued depositary shares representing interests in fixed-rate reset non-cumulative preferred stock
Auna $62.1 million senior secured notes offering
We advised Auna on the offering
Biogen $1.75 billion senior notes offering
The investment-grade notes are due 2031, 2035 and 2055
Hub International $1.6 billion private placement
The transaction was part of Hub International’s liquid private placement program
Primo Brands $1.5 billion secondary offering
The shares are listed on the New York Stock Exchange
Hertz $1.66 billion revolving credit facility maturity extension
We advised Hertz on the transactions
NOVAGOLD $243.8 million upsized public offering and concurrent private placement
The shares are listed on the New York Stock Exchange American and the Toronto Stock Exchange
EQT $500 million debut notes offering
The investment-grade notes are due 2035